Genelux GNLX
NASDAQ GNLX
$1.98 -0.09 (-4.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genelux (GNLX) Accumulated Expenses (2022 - 2025)

Updated

Genelux (GNLX) recorded Accumulated Expenses of $5.8 million in Q4 2025, down 11.8% from $6.57 million a year earlier.

Analysis

Genelux (GNLX) Accumulated Expenses (2022 - 2025) Analysis & Trends

  • Across earlier years, Accumulated Expenses came in at $6.57 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Genelux 88.08 Mn 26.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.80 Mn
Dec 31, 2024 6.57 Mn
Dec 31, 2023 20,000.00
Sep 30, 2023 20,000.00
Dec 31, 2022 1.18 Mn
API Access

Genelux Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=GNLX&period=max&api_key=YOUR_API_KEY